SinoMab Pty Ltd Report issue

For profit Phase 1 Phase 3
Founded: Australia (2001)

Organization Overview

First Clinical Trial
2012
NCT04704492
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

SinoMab BioScience Ltd | SinoMab Pty Ltd

Active Ingredients

Drugs in Phase 3 Trials (2)

methotrexate (2 trials)

sm03 (3 trials)

Drugs in Phase 1 Trials (2)

sm17 (1 trial)

sn1011 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 3)

Arthritis, Rheumatoid (Phase 3)

Autoimmune Diseases (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4